synacthen depot 1mg/ml amp.
novartis pharma egypt - injection - 1 mg/ml
livtencity- maribavir tablet, coated
takeda pharmaceuticals america, inc. - maribavir (unii: ptb4x93he1) (maribavir - unii:ptb4x93he1) - livtencity is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (cmv) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet [see use in specific populations (8.4) and clinical studies (14)] . none. risk summary no adequate human data are available to establish whether livtencity poses a risk to pregnancy outcomes. in animal reproduction studies, embryo-fetal survival was decreased in rats, but not in rabbits, at maribavir exposures less than those observed in humans at the recommended human dose (rhd) (see data) . the background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. data animal data in a combined ferti
city/flunixin
city pharma a.r.e - flunixin meglumine 8.3 gm equivalent to 5 gm flunixin. - injectable solution
city/oxytet 5%
city pharma - oxytetracycline hcl 62.5 mg (equivalent to oxytetracycline base 50 mg)/1ml - solution for injection
tonofungyn capsules hard
egyptian international pharmaceutical industries company (eipico) - fluconazole - capsules hard - 150mg
velocity™ disposable arthroscopic blades and burs
micro asia trading pte. ltd. - orthopaedics - disposable shaver blades and burrs are use to shave or bur away damaged soft tissue and bone during arthroscopic joint surgeries.
dexatrol eye drops
averroes pharmaceuticals sdn. bhd. - dexamethasone; neomycin sulphate; polymyxin b sulphate -
livtencity tablet
takeda canada inc - maribavir - tablet - 200mg - maribavir 200mg
prevenar 13
pfizer pharmaceuticals israel ltd - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19 f; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 9v - suspension for injection - pneumococcal polysaccharide serotype 23f 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 19 f 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 14 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 9v 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 7f 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6b 4.4 mcg / 0.5 ml; pneumococcal polysaccharide serotype 5 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 4 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 1 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 3 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6a 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 18c 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 19a 2.2 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen conjugated - pneumococcus, purified polysaccharides antigen conjugated - active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to 17 years of age.active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in adults ≥18 years of age and the elderly
abilify 15mg tab.
otsuka pharmaceutical-japan - tablet - 15 mg